Drugs with this side effect
- 1,25(OH)2D3: postmarketing, 1% - 3%
- 17-hydroxyprogesterone: 5.9% - 7.7%
- 18F-FDG
- 2-hydroxysuccinaldehyde: 12% - 21%
- 5-ASA: postmarketing, uncommon, 0.565% - 10%
- 5-FU
- 5-aminolevulinic acid: 0% - 25%
- 5-aza-2'-deoxycytidine: 2.47% - 10.8%
- 5-azacytidine: common, very common, 0% - 12.3%
- 5-fluorocytosine
- 68Ga
- 8-MOP
- A77 1726: 2.79% - 3%
- AMD3100
- Almeta
- Anidulafungin: 2.3%
- BPTI
- Buscopan
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- CGP 19835A: common
- Cancidas: 0% - 8%
- DFMO: 3.1% - 4%
- EACA
- Enfuvirtide: 3% - 65%
- Estrofem
- FAMP
- FK463: 0% - 32.6%
- FTY720: common, 2.59% - 3%
- Fe(III: postmarketing, 0% - 6%
- Forteo: common
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132: 7%
- Glat copolymer
- Goserelin: 0% - 6%
- Histrelin
- Humalog
- ICI 182,780: postmarketing
- Implanon: postmarketing
- Insulin: uncommon, common
- K779: 1% - 29%
- Kaluril
- L-Dmp: frequent
- LMWH: postmarketing
- LY146032: postmarketing, common, 2.8% - 5.83%
- Lantus
- Leuprorelin
- Lisinopril: postmarketing, uncommon, 0.5% - 1.4%
- Locorten Vioform
- Lovaza
- Lu AA21004: 1% - 3%
- Lutalyse
- MDV3100: 0% - 3.8%
- MK-462
- Meropenem anhydrous: 1.2%
- Mersyndol
- Metrodin: postmarketing
- MnDPDP
- N-acetylcysteine: 0.917% - 4.3%
- NSC 352122
- NTBC: uncommon
- Nafarelin
- NovoLog: very rare, uncommon
- NuvaRing
- Nuvocid
- Octreotide: common, 0-4% - 4.4%
- Oestrogen: uncommon, 4% - 5%
- Optison: postmarketing, uncommon
- PGE1
- Paroven
- Photofrin: 1.01% - 5.94%
- Photofrin II: common
- Prednefrin
- Promacta
- Refludan
- Romidepsin: 0% - 31.3%
- S-benzoylmercaptoacetyltriglycine
- SOM230: 7.32% - 8.75%
- SU5416
- Saxagliptin
- Signifor: 7.32% - 8.75%
- SonoVue
- Stalevo 50
- Supremon: 1.3%
- T-A2-3
- TMC435: 11% - 21.5%
- TPGS
- TR-700
- Tadenan: 0.4%
- Timentin
- TlCl
- Triptorelin: 1.4%
- Trisequens
- UDCA: postmarketing, 5%
- VACV: postmarketing, rare, 0% - 5%
- Vancocine: postmarketing
- Westcort: 2% - 6%
- Zyprexa Relprevv
- abacavir: 17%
- acamprosate: common, 3% - 4%
- acebutolol
- acetaminophen: postmarketing, 3.3%
- acipimox
- acitretin: postmarketing, 10-50%
- acyclovir: postmarketing, common
- adapalene: 0% - 1.9%
- adefovir
- adefovir dipivoxil: postmarketing, common
- afatinib: very common, 0% - 21%
- agomelatine: uncommon
- alclometasone
- alendronate: postmarketing
- alfentanil
- alfuzosin: postmarketing, uncommon, 1.4%
- aliskiren: postmarketing, uncommon
- allopurinol
- almotriptan: infrequent
- alprazolam: 1.1%
- amantadine: postmarketing
- ambrisentan
- amcinonide
- amifostine
- amiloride
- aminoglutethimide
- amiodarone: postmarketing
- amisulpride: 0% - 1%
- amitriptyline
- amlodipine
- amlodipine besylate
- amorolfine
- amoxapine
- amoxicillin: uncommon
- amphotericin B: 10.2% - 10.8%
- ampicillin
- amprenavir
- anagrelide: 5.5% - 6%
- anastrozole
- anthracycline: 0% - 14%
- apomorphine: 2%
- apraclonidine: 10%
- aprepitant: postmarketing, 7.6% - 8.4%
- aripiprazole: postmarketing
- arsenic
- arsenic trioxide
- articaine
- aspirin
- atazanavir: postmarketing, uncommon
- atenolol
- atomoxetine: common
- atorvastatin
- atosiban
- atovaquone: 5%
- atracurium: 0% - 0.4%
- atropine
- auranofin: 17%
- avanafil
- axitinib: 0% - 12%
- azelaic acid: 0% - 11%
- azelastine: postmarketing
- azilsartan: postmarketing
- azilsartan medoxomil
- azithromycin: postmarketing, 0% - 3.9%
- aztreonam
- baclofen: common, 0% - 8%
- balsalazide: postmarketing
- bazedoxifene
- belinostat: 3% - 16%
- benazepril
- benazeprilat
- bendamustine: postmarketing, 0% - 5.23%
- benzathine penicillin
- benzocaine
- benzonatate
- benzoyl: common
- benzyl alcohol
- benzylpenicilloyl
- bepotastine: postmarketing
- betahistine
- betamethasone dipropionate
- betamethasone valerate: common
- betaxolol
- bexarotene: very common, 18% - 40%
- bezafibrate: 3.4%
- bicalutamide: postmarketing, common, 3%
- bile salt
- bimatoprost: very common
- bisoprolol: postmarketing, rare
- bleomycin hydrochloride
- boceprevir: very common, 18%
- bortezomib: 0% - 12%
- bosentan: uncommon, 2% - 4%
- bosutinib: 0%
- brimonidine: postmarketing, very common, 1% - 9.8%
- brinzolamide: 0.9% - 1.2%
- bromazepam: postmarketing
- bromhexine
- budesonide: postmarketing
- bumetanide: 0.4%
- bupivacaine: 0% - 9%
- buprenorphine: 3% - 4%
- bupropion: 1% - 5%
- buspirone: infrequent
- busulfan: 28% - 29%
- butenafine
- butoconazole
- butorphanol
- cabergoline: 0.905% - 1%
- calcipotriol
- calcium
- calcium acetate
- canagliflozin
- candesartan: postmarketing
- candesartan cilexetil: postmarketing
- capecitabine: 5%
- capsaicin: uncommon, 1% - 2%
- captopril
- carbamazepine: rare, 5% - 8%
- carbenicillin
- carbidopa
- carbimazole
- carboplatin
- carnitine: 3% - 8%
- carvedilol
- cefaclor
- cefadroxil
- cefazolin: postmarketing
- cefdinir
- cefditoren
- cefepime: 1%
- cefixime: postmarketing
- cefotaxime
- cefotetan
- cefoxitin
- cefpodoxime
- cefprozil: 0.3%
- ceftaroline
- ceftazidime: uncommon
- ceftizoxime
- ceftobiprole
- ceftriaxone: 0.1 - 1.0%
- cefuroxime: postmarketing
- cefuroxime axetil
- celecoxib
- cephalexin
- cephem
- cerivastatin
- cetirizine: postmarketing, 0.201%
- cetrorelix
- cevimeline
- chlorambucil
- chloramphenicol
- chloroprocaine
- chloroquine
- chlorpropamide
- ciclopirox: common
- cidofovir: postmarketing
- cilazapril
- cilostazol: postmarketing
- cinacalcet: 6%
- cinoxacin
- ciprofloxacin: uncommon, 1.1% - 1.2%
- cisatracurium: 0.2%
- citalopram: infrequent, uncommon, frequent, 1%
- cladribine: common, 2% - 6%
- clarithromycin: postmarketing, common
- clindamycin: postmarketing, 0.595% - 60%
- clindamycin phosphate: 1.1%
- clobazam
- clobetasol: postmarketing, 0.538% - 7.09%
- clobetasol propionate
- clobetasone butyrate: very rare
- clocortolone
- clodronate
- clofarabine: very common, 20%
- clofazimine
- clomiphene citrate: postmarketing
- clomipramine: common, 2% - 6%
- clonazepam
- clonidine
- clopidogrel: very rare, postmarketing, uncommon
- clozapine
- cobicistat: uncommon
- codeine
- colestimide: uncommon
- conivaptan
- conjugated estrogens: postmarketing, 0.714% - 5.03%
- copolymer 1
- cortisol: 1.44% - 13.8%
- cosyntropin
- crotamiton
- cyanocobalamin
- cyclizine
- cyclobenzaprine
- cyclopentolate
- cyclophosphamide: postmarketing
- cyproterone
- cyproterone acetate
- cytarabine: 0% - 14.3%
- d-telaprevir: very common, 28%
- dabigatran
- dabigatran etexilate: uncommon
- dabrafenib: 0% - 13%
- dalbavancin: 2.14% - 3.35%
- dalteparin
- danazol
- dantrolene
- darifenacin
- darunavir: 8.3%
- dasatinib: 0% - 11%
- deferasirox: common
- deferiprone: postmarketing
- deferoxamine: very common
- degarelix
- delamanid
- delavirdine
- delta 9-THC
- demethyl
- deprenyl: frequent
- desflurane: postmarketing
- desipramine
- desloratadine: postmarketing
- desmopressin
- desonide
- desoximetasone
- dexamethasone
- dexpanthenol
- dexrazoxane
- dextrorphan
- diatrizoate
- diazepam
- diazoxide
- dichlorphenamide
- diclofenac: very rare, postmarketing, 1% - 59%
- dicloxacillin: common
- dicyclomine: postmarketing
- didanosine: 5% - 9%
- diflorasone diacetate
- diflunisal
- dihydrocodeine: uncommon
- dihydroergotamine: infrequent
- diltiazem
- dimercaptosuccinic acid
- dipyridamole
- disopyramide
- dobutamine
- docetaxel
- dolasetron: 2.2% - 3.07%
- dolutegravir
- domperidone
- donepezil: frequent
- doripenem: common, 0.1% - 3%
- dorzolamide: postmarketing
- doxapram
- doxazosin: postmarketing, 1% - 2%
- doxepin: rare, 3.94% - 5.99%
- doxercalciferol: 8.2%
- doxorubicin: postmarketing, common
- dronedarone: 5%
- duloxetine: postmarketing, common, frequent, 3%
- dutasteride: postmarketing
- ecallantide: 5%
- econazole
- efavirenz: common, 0% - 9.8%
- eletriptan: infrequent
- eltrombopag
- emedastine
- empagliflozin
- emtricitabine: postmarketing, common
- entacapone
- epinastine
- epitopic
- eplerenone: common
- eprosartan
- ergotamine
- eribulin: postmarketing
- erlotinib: 0% - 16%
- ertapenem: 0% - 2%
- erythromycin
- erythromycin lactobionate
- eslicarbazepine acetate
- esmolol
- esomeprazole magnesium
- estazolam: infrequent, 1%
- estradiol: postmarketing, common, 0.5% - 7.8%
- estradiol cypionate
- estradiol valerate
- estramustine: 2%
- estramustine phosphate
- estriol
- estrone
- ethambutol
- etidronate: postmarketing
- etodolac
- etoposide
- etoposide phosphate
- etoricoxib
- everolimus: common, very common, 0% - 21%
- exemestane: postmarketing, 2-5%
- exenatide: 8%
- ezetimibe
- famciclovir: very rare, postmarketing, common, 0% - 3.7%
- famotidine
- febuxostat
- felbamate: frequent
- felodipine
- fenofibrate: uncommon, 2.1%
- fenoprofen
- fentanyl: very rare, postmarketing, 0% - 13%
- ferumoxytol: postmarketing, 0.4% - 1.2%
- fesoterodine: postmarketing
- fexofenadine: postmarketing
- fidaxomicin: postmarketing
- finasteride: postmarketing
- flecainide
- florbetapir: uncommon
- fluconazole: postmarketing
- fludarabine: 1% - 3%
- flumazenil
- flumethasone
- flunisolide
- fluocinolone
- fluocinolone acetonide: 0% - 5.26%
- fluocinonide: postmarketing
- fluorescein: postmarketing, common
- fluoxetine: common, 3%
- fluphenazine
- fluphenazine decanoate
- flurandrenolone
- flurazepam
- flurbiprofen
- flutamide
- fluticasone: postmarketing, 0.452% - 5.13%
- fluticasone propionate: postmarketing, 0.493% - 5.13%
- fluvastatin: postmarketing
- fluvoxamine: infrequent, uncommon
- folate
- fondaparinux: uncommon
- formoterol: rare, 1.5%
- fosamprenavir: common
- fosaprepitant
- fosaprepitant dimeglumine: postmarketing, 7.6% - 8.4%
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril
- fosinoprilat
- fosphenytoin: 0% - 48.9%
- fospropofol: 16.1% - 27.6%
- fotemustine
- frovatriptan: infrequent
- furosemide
- fusidic acid
- gabapentin: infrequent, 0.5% - 1.3%
- gadobenate dimeglumine: postmarketing
- gadodiamide
- gadofosveset
- gadolinium: 0.2% - 0.3%
- gadopentetate
- gadoteridol: 0.08% - 0.25%
- gadoversetamide
- ganciclovir: 2.5% - 3.2%
- gatifloxacin: postmarketing
- gefitinib: common, very common, 0% - 35.8%
- gemcitabine: common, very common
- gemfibrozil: 0.8%
- gemifloxacin
- gentamicin
- glibenclamide
- gliclazide: 0.4% - 1%
- glimepiride
- glipizide
- glutamine: 0% - 11.1%
- glycerol
- glycopyrrolate
- gold sodium thiomalate
- gonadorelin
- granisetron
- guanfacine: postmarketing
- halobetasol
- halofantrine: 2.6%
- haloperidol: very rare, postmarketing
- heparin: postmarketing
- hepatitis B vaccines: rare
- hetastarch: postmarketing
- histamine
- hydralazine: uncommon
- hydrochlorothiazide
- hydrocodone: 0% - 2.55%
- hydrocortisone butyrate
- hydromorphone: 0.746% - 7.8%
- hydroxocobalamin
- hydroxychloroquine
- ibandronate
- ibuprofen: 1%
- icodextrin
- ifosfamide: postmarketing
- imatinib: common, 0% - 25.8%
- imipramine: very rare
- imiquimod: uncommon, 0.4% - 32.5%
- indacaterol: postmarketing, uncommon
- indapamide
- indinavir: postmarketing, 1.8% - 4.2%
- indomethacin: 2% - 4%
- insulin detemir
- iodide
- iodixanol: 1.6% - 4.2%
- iohexol
- iopamidol
- iopromide
- ioversol
- ioxaglate
- ioxilan
- ipratropium bromide: postmarketing, uncommon
- irbesartan: uncommon
- irbesartan-hydrochlorothiazide
- iron sucrose
- isomannide
- isopropyl unoprostone
- isosorbide-5-mononitrate
- isosulfan blue: postmarketing
- isradipine
- itraconazole: postmarketing, 1% - 3%
- ivabradine
- ivermectin: 2.8% - 27.5%
- ixabepilone: 0% - 6%
- ketoconazole: postmarketing
- ketoprofen
- ketorolac
- ketorolac tromethamine: postmarketing
- ketotifen
- labetalol: 0.6%
- lacosamide: 0% - 6%
- lamivudine: postmarketing, common, 1%
- lamotrigine: 2% - 6%
- lanreotide
- lansoprazole
- lapatinib: very common, 0% - 9%
- lasofoxifene: uncommon
- latanoprost: 0.8% - 2%
- leflunomide: postmarketing, common, 2% - 6%
- lenalidomide: postmarketing, very common, 0.746% - 44.6%
- lercanidipine
- letrozole: uncommon, 1% - 5%
- leucovorin: postmarketing
- leuprorelin acetate: 0.4% - 1.4%
- levetiracetam: common, 2%
- levobunolol
- levodopa/carbidopa
- levonorgestrel
- lincomycin
- lindane: postmarketing
- linezolid: 0% - 2%
- liraglutide: postmarketing
- lithium carbonate
- lodoxamide
- lodoxamide tromethamine: 3.5%
- lomefloxacin
- loperamide: postmarketing
- lormetazepam
- losartan
- loteprednol etabonate
- lovastatin: postmarketing
- loxapine
- lurasidone: frequent
- lymecycline
- mafenide acetate: 2.8%
- malvidin: 1% - 8.8%
- mannitol
- maprotiline
- maraviroc: 2% - 4%
- meclofenamate
- medroxyprogesterone: postmarketing
- medroxyprogesterone acetate: postmarketing, 0.2 - 1%
- mefenamic acid
- mefloquine: postmarketing, common
- megestrol
- melatonin
- meloxicam: 0% - 2.4%
- melphalan: rare
- memantine: infrequent
- meperidine
- mepivacaine
- meprobamate
- meropenem: 0.6% - 1.2%
- metaiodobenzylguanidine
- metaproterenol: 0.4% - 2%
- metaxalone
- metformin
- methacholine
- methadone
- methenamine silver
- methimazole
- methocarbamol
- methohexital
- methotrexate
- methyl aminolevulinate: 0% - 22.2%
- methylene diphosphonate
- methylphenidate: postmarketing, common, 0% - 3%
- methylprednisolone
- methylprednisolone sodium succinate
- metolazone
- metoprolol: postmarketing, common
- metronidazole: 1% - 19%
- mianserin
- miconazole: 0.7% - 2%
- midazolam: uncommon
- midodrine: common, 2.3% - 12.2%
- mifepristone: 4%
- milnacipran: 2% - 3%
- minocycline: 4.6%
- mipomersen: 29%
- mirabegron
- mirtazapine: postmarketing, frequent
- moclobemide
- modafinil: postmarketing, 1%
- moexiprilat
- mometasone: postmarketing
- mometasone furoate
- monomethylfumarate: 8%
- montelukast: postmarketing
- morphine: postmarketing
- moxifloxacin
- moxonidine: postmarketing
- mupirocin: uncommon, 1% - 2.4%
- mycophenolate mofetil: 10.5% - 14.1%
- mycophenolic acid
- n-3 PUFA
- nabilone
- nabumetone: 4%
- nadolol
- nafcillin
- naftifine: postmarketing, 1% - 2%
- nalbuphine
- nalidixic acid
- nalmefene
- naltrexone
- nandrolone decanoate
- naproxen: postmarketing
- naratriptan: infrequent
- nateglinide: rare
- nebivolol: postmarketing
- nefazodone
- nelfinavir
- neomycin
- neostigmine
- nepafenac
- nesiritide: postmarketing, 0% - 2%
- nevirapine
- niacin: 0% - 3%
- nicorandil: uncommon
- nicotine: 1.9% - 2%
- nifedipine: 1.1%
- nilotinib: 0% - 24%
- nilutamide: 2%
- nimodipine
- nisoldipine
- nitazoxanide
- nitrazepam
- nitrogen mustard: 2% - 20%
- nitroglycerin: uncommon, common
- nizatidine: 1.7%
- norethisterone
- norfloxacin: postmarketing
- nortriptyline
- nystatin
- ofatumumab
- ofloxacin: 1% - 4%
- ogen
- olanzapine: postmarketing, infrequent
- olmesartan: postmarketing
- olmesartan medoxomil
- olopatadine
- olsalazine: 1.13% - 1.3%
- omeprazole: postmarketing, uncommon, 1.1%
- ondansetron: 1.65% - 4.91%
- orlistat: postmarketing, uncommon
- orphenadrine
- oxacillin
- oxaliplatin
- oxaprozin
- oxcarbazepine
- oxiconazole: 1.6%
- oxprenolol
- oxybutynin: very common, 1.3% - 1.5%
- oxycodone: 12% - 14%
- oxymorphone: 0% - 15.2%
- paclitaxel: postmarketing, rare, very common
- paliperidone
- palonosetron
- pamidronate: postmarketing, uncommon
- pantoprazole: uncommon
- parecoxib
- paricalcitol: 2.8% - 3%
- paroxetine: infrequent, uncommon, common, frequent
- pazopanib
- pegaptanib
- pemetrexed: 0% - 7%
- penciclovir: postmarketing, 0% - 3.7%
- penicillin
- pentamidine
- pentastarch
- pentazocine
- pentosan polysulfate: 0%
- pentostatin: 6% - 21%
- pentoxifylline: postmarketing
- pergolide: infrequent
- perindopril
- perindopril erbumine
- permethrin
- perphenazine
- phencyclidine
- phenelzine
- phentolamine
- phenylazo
- phenylephrine
- phenyllactate
- phenytoin: 0% - 48.9%
- phosphate
- pilocarpine
- pimecrolimus: postmarketing, common
- pimozide: postmarketing
- pindolol: 0% - 1%
- piperacillin: uncommon
- pirbuterol
- pirfenidone
- piroxicam: 1.1%
- pitavastatin
- pixantrone
- podophyllotoxin: 7.8% - 65%
- pomalidomide: 10.7% - 15%
- ponatinib
- posaconazole
- pralatrexate
- pramipexole: postmarketing, uncommon, 1.4%
- pravastatin: 0.9%
- praziquantel: postmarketing
- prazosin: 1%
- prednicarbate
- prednisolone acetate
- prednisolone phosphate
- prednisone
- pregabalin: postmarketing, infrequent, frequent
- probenecid
- procainamide
- procaine
- procarbazine
- prochlorperazine
- progesterone: postmarketing
- promethazine
- propafenone: postmarketing
- propofol
- propylthiouracil
- prostacyclin
- protriptyline
- pyrazinamide
- quetiapine: infrequent
- quinapril
- quinaprilat
- quinidine
- rabeprazole
- raltegravir
- raltitrexed: 2%
- ramipril
- ramiprilat
- ranitidine
- ranolazine: postmarketing
- rapamycin
- rasagiline
- remifentanil: common, 0% - 17.6%
- repaglinide
- rescinnamine
- reserpine
- retapamulin: 1% - 1.5%
- retinoic acid: postmarketing, very common, 0.616% - 30%
- ribavirin: common, very common, 11% - 27%
- rifabutin
- rifampicin
- rifapentine
- rifaximin: postmarketing, 9.29%
- riluzole: 2.5% - 3.8%
- rimexolone
- rimonabant
- risedronate: rare
- risperidone: infrequent, 0% - 2%
- ritonavir
- rivaroxaban: 1.75% - 2.14%
- rivastigmine: postmarketing, rare, frequent, 1.7% - 2%
- rizatriptan: infrequent
- rocuronium
- rofecoxib
- ropinirole: postmarketing, infrequent, frequent
- ropivacaine: 0.3% - 9%
- rosiglitazone: very rare, postmarketing
- rosuvastatin: uncommon
- rotigotine: 9%
- roxithromycin
- rufinamide: 3%
- ruxolitinib
- salbutamol: postmarketing
- salicylate
- salmon calcitonin acetate: postmarketing, rare
- saquinavir: common
- scopolamine: postmarketing
- sertaconazole: postmarketing
- sertraline: postmarketing, infrequent, uncommon, frequent
- sevelamer: postmarketing, 4%
- sevelamer carbonate: postmarketing
- sevelamer hydrochloride: postmarketing, 4.1% - 13.1%
- sevoflurane: postmarketing
- sibutramine
- sildenafil
- silodosin: postmarketing
- simvastatin: postmarketing, 0.5%
- sodium: postmarketing
- sodium ferric gluconate: 0.5% - 6%
- sodium iodide
- sodium iothalamate
- sofosbuvir: common, very common, 8% - 27%
- solifenacin: postmarketing
- sorafenib: postmarketing, 0% - 19%
- sotalol: postmarketing
- sparfloxacin: 1.8% - 3.3%
- spironolactone
- stavudine: common
- strontium ranelate: postmarketing
- sufentanil: 25%
- sulconazole
- sulfacetamide
- sulfadiazine
- sulfamethoxazole
- sulfasalazine: 4%
- sulindac
- sumatriptan: postmarketing, rare, infrequent
- sunitinib
- suprofen
- tacrolimus: common, 7% - 46%
- tadalafil
- tafluprost
- tamoxifen
- tamsulosin: postmarketing, uncommon, 1%
- tapentadol: 5% - 8%
- tazarotene: 1% - 10%
- technetium-99m
- tegaserod: postmarketing, 0% - 1%
- telavancin: common, 6% - 13%
- telithromycin
- telmisartan: rare, uncommon
- temazepam
- temozolomide: common, 0% - 7.59%
- temsirolimus
- teniposide
- tenofovir: 16%
- tenofovir disoproxil fumarate: 16%
- tenoxicam: uncommon
- terazosin
- terbinafine: common, 0% - 4%
- terconazole: 2.3%
- tesamorelin: 0.7% - 2.4%
- testosterone: postmarketing, very common, 1.85% - 39%
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- thalidomide: 2.78% - 8.33%
- theophylline
- thiabendazole
- thiamine
- thiotepa: 1-10%
- thiothixene
- thymidine: 2.13% - 3%
- thyroxine
- tiagabine: 2%
- tiaprofenic acid: 1.7% - 7.2%
- tibolone
- ticagrelor
- ticlopidine
- tigecycline: common, 2.6% - 4.1%
- timolol: postmarketing, 1.1%
- tinidazole: postmarketing
- tiopronin
- tiotropium: postmarketing
- tipranavir: uncommon, common
- tizanidine: infrequent
- tobramycin: uncommon
- tofacitinib
- tolazamide
- tolbutamide
- tolcapone: infrequent
- tolvaptan: common
- topiramate: 0% - 4%
- topotecan: postmarketing, common
- toremifene
- tramadol: uncommon, 3.03% - 11.9%
- tramazoline
- trametinib: 0% - 13%
- trandolapril: postmarketing, 0.5%
- trandolaprilat
- trans 4-cyclohexyl-L-proline
- travoprost: 0.7% - 5.6%
- trazodone: postmarketing, 0% - 2.8%
- treprostinil: 8%
- triamcinolone: postmarketing
- triamcinolone acetonide: postmarketing
- triazolam
- trifluoperazine
- trimethadione
- trimethoprim
- trimetrexate: 2.75% - 12.6%
- trimipramine
- tropicamide
- trospium chloride
- trovafloxacin: 1% - 2%
- unoprostone
- ustekinumab: uncommon, common, 2%
- v 1784: postmarketing
- valdecoxib
- valganciclovir: 4% - 7%
- valproate
- valrubicin
- valsartan: very rare
- vandetanib: 0.4% - 11%
- vardenafil
- varenicline: uncommon, 0% - 1%
- vemurafenib: postmarketing, 0% - 30%
- venlafaxine: very rare, postmarketing, frequent
- verapamil
- vernakalant: common
- verteporfin
- vigabatrin: postmarketing
- vinflunine
- vinorelbine: postmarketing
- vismodegib
- voriconazole: common, 0% - 1.08%
- vorinostat
- warfarin
- zafirlukast
- zalcitabine
- zaleplon: frequent
- ziconotide: 7%
- zidovudine: postmarketing, uncommon
- zidovudine/lamivudine
- zileuton
- zoledronic acid: uncommon
- zolmitriptan: infrequent
- zolpidem: postmarketing, rare, infrequent
- zonisamide: frequent
- zopiclone: 1% - 4%
- zuclopenthixol
|
Drugs with this indication
|
